The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies-A Pilot Study.
Oesch-Régeni, Boglárka, Germann, Nicolas, Hafer, Georg et al.·Journal of clinical medicine·2025
This small pilot study looked at seven ME/CFS patients who had high levels of specific antibodies (proteins the immune system makes) that may harm certain nerve and heart functions. The researchers gave these patients two types of blood-cleaning treatments—plasmapheresis (which filters antibodies out of blood) and immunoglobulins (healthy antibodies)—and tracked their symptoms and quality of life. They found that patients with higher levels of these harmful antibodies tended to report worse quality of life, and the treatments appeared to help reduce both the antibodies and improve how patients felt.